The Protective Effect of Heme Oxygenase-1 against Intestinal Barrier Dysfunction in Cholestatic Liver Injury Is Associated with NF-κB Inhibition

Abstract Heme oxygenase-1 (HO-1) is reported to protect against liver injury, but little Is known about its effect on the intestinal barrier in cholestatic liver injury. In this study, we investigated the effects of HO-1 and its enzymatic by-product on intestinal barrier dysfunction in bile duct lig...

Full description

Saved in:
Bibliographic Details
Main Authors: Lijing Zhang (Author), Zhenling Zhang (Author), Bojia Liu (Author), Yanling Jin (Author), Yan Tian (Author), Yi Xin (Author), Zhijun Duan (Author)
Format: Book
Published: BMC, 2017-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_94b1d7ebe6fb4900b3ce13d0b0b4897c
042 |a dc 
100 1 0 |a Lijing Zhang  |e author 
700 1 0 |a Zhenling Zhang  |e author 
700 1 0 |a Bojia Liu  |e author 
700 1 0 |a Yanling Jin  |e author 
700 1 0 |a Yan Tian  |e author 
700 1 0 |a Yi Xin  |e author 
700 1 0 |a Zhijun Duan  |e author 
245 0 0 |a The Protective Effect of Heme Oxygenase-1 against Intestinal Barrier Dysfunction in Cholestatic Liver Injury Is Associated with NF-κB Inhibition 
260 |b BMC,   |c 2017-08-01T00:00:00Z. 
500 |a 10.2119/molmed.2017.00078 
500 |a 1076-1551 
500 |a 1528-3658 
520 |a Abstract Heme oxygenase-1 (HO-1) is reported to protect against liver injury, but little Is known about its effect on the intestinal barrier in cholestatic liver injury. In this study, we investigated the effects of HO-1 and its enzymatic by-product on intestinal barrier dysfunction in bile duct ligation (BDL) rats and explored the possible mechanism. The HO-1 inducer cobalt protoporphyrin (CoPP) and carbon monoxide-releasing molecule-2 (CORM-2) were used; the expression levels of tight junction (TJ) proteins, intestinal inflammation and NF-κB p65 were measured. For an in vitro experiment, stable Caco-2 cell lines were constructed, one overexpressed the HO-1 gene and another with that gene knocked down, and the specific NF-κB inhibitor JSH-23 was used. CoPP and CORM-2 treatment alleviated liver and intestinal mucosa injury in BDL rats; improved ZO-1, claudin-1 and PCNA expression; and reduced cell apoptosis and intestinal interleukin-6 (IL-6) expression. In vitro studies confirmed that HO-1, ZO-1 and occludin were overex-pressed in HO-1-transfected Caco-2 cells, while decreased in the short hairpin HO (sh-HO-1) group. JSH-23 significantly increased occludin expression in both the HO-1 overexpression and sh-HO-1 groups, compared with their respective controls. HO-1 overexpression also inhibited the nuclear translocation of NF-κB p65 after lipopolysaccharide (LPS) treatment. Additionally, phospho-p65 expression in sh-HO-1 cells was significantly increased compared with that of the HO-1 overexpression group. In conclusion, HO-1 and CORM-2 improved intestinal epithelial barrier function in BDL-induced cholestatic liver injury mainly by restoring TJ, reducing cell apoptosis and intestinal inflammation. HO-1 exerts a protective effect, which is partially correlated with the regulation of NF-κB. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Biochemistry 
690 |a QD415-436 
655 7 |a article  |2 local 
786 0 |n Molecular Medicine, Vol 23, Iss 1, Pp 215-224 (2017) 
787 0 |n http://link.springer.com/article/10.2119/molmed.2017.00078 
787 0 |n https://doaj.org/toc/1076-1551 
787 0 |n https://doaj.org/toc/1528-3658 
856 4 1 |u https://doaj.org/article/94b1d7ebe6fb4900b3ce13d0b0b4897c  |z Connect to this object online.